Comparison of attenuated and virulent West Nile virus strains in human monocyte-derived dendritic cells as a model of initial human infection by unknown
Rawle et al. Virology Journal  (2015) 12:46 
DOI 10.1186/s12985-015-0279-3SHORT REPORT Open AccessComparison of attenuated and virulent West Nile
virus strains in human monocyte-derived dendritic
cells as a model of initial human infection
Daniel J Rawle†, Yin Xiang Setoh†, Judith H Edmonds and Alexander A Khromykh*Abstract
Background: The human-pathogenic North American West Nile virus strain (WNVNY99), responsible for the outbreak
in New York city in 1999, has caused 41000 infections and 1739 human deaths to date. A new strain of West Nile
virus emerged in New South Wales, Australia in 2011 (WNVNSW2011), causing a major encephalitic outbreak in horses
with close to 1000 cases and 10-15% mortality. Unexpectedly, no human cases have so far been documented.
Findings: We report here, using human monocyte-derived dendritic cells (MoDCs) as a model of initial WNV infection,
that the pathogenic New York 99 WNV strain (WNVNY99) replicated better than WNVNSW2011, indicative of increased viral
dissemination and pathogenesis in a natural infection. This was attributed to suppressed viral replication and type I
interferon (IFN) response in the early phase of WNVNY99 infection, leading to enhanced viral replication at the later
phase of infection. In addition, WNVNY99 induced significantly more pro-inflammatory cytokines in MoDCs compared to
WNVNSW2011.
Conclusions: Our results suggest that the observed differences in replication and induction of IFN response between
WNVNY99 and WNVNSW2011 in MoDCs may be indicative of their difference in virulence for humans.
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West Nile virus (WNV) is the leading cause of arboviral
encephalitis in the Americas with over 41000 infections
and 1739 human deaths (http://www.cdc.gov/westnile/
index.html, accessed 25/11/2014) since the outbreak of a
human virulent strain in New York in 1999 (WNVNY99
strain) [1,2]. There is currently no effective treatment or
approved WNV vaccine for use in humans. A strain of
WNV called Kunjin (WNVKUN) has been circulating in
Australia since it was discovered in 1960, and have
caused very few symptomatic infections in humans or
horses [3]. This was until a new strain of WNV emerged
in New South Wales in 2011 (WNVNSW2011) causing a
major encephalitic outbreak in over 1000 horses [4,5].
WNVNSW2011 has likely emerged through mutations of
previously circulating WNVKUN, and gained at least two* Correspondence: alexander.khromykh@uq.edu.au
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unless otherwise stated.known virulence determinants found in the human-
pathogenic WNVNY99 strain [4]; i) the N-linked glycosyla-
tion on the E protein associated with increased virulence
in mice [6], and ii) the phenylalanine residue at position
653 of NS5 which is a potent inhibitor of STAT1 phos-
phorylation [7].
The horses affected by the WNVNSW2011 outbreak pre-
sented with similar clinical symptoms to horses infected
with WNVNY99, therefore it was rather unexpected that
the WNVNSW2011 outbreak had no reported human
cases. This prompted us to investigate the viral growth
kinetics and immune induction profiles of WNVNSW2011
compared to WNVNY99 using cultures of primary hu-
man dendritic cells (DCs) as a model of initial infection
in humans [8-11]. Human MoDCs were used as an
ex vivo model of initial WNV infection in this study, be-
cause it has been shown that large numbers of bone
marrow monocytes differentiate into DCs soon after
WNV infection in the dermis [12]. Human MoDCs have
been previously used to show that WNV replication was
required for type I IFN induction, and this was a resultThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Replication of WNVNY99 and WNVNSW2011 in human MoDCs. MoDCs from donors 1 (a, b), 2 (c, d) and 3 (e, f) were infected with
WNVNY99 and WNVNSW2011 at MOI = 1. Cell culture supernatant was collected at 24, 48 and 72 hours post-infection and virus titer was determined
by plaque assay on BHK cells (a, c, e). Total cellular RNA was collected at 24, 48 and 72 hpi and vRNA levels as determined by qRT-PCR were
normalised to a combination of three endogenous controls (TBP, GAPDH and PPIA), and was expressed as fold change from uninfected samples
(b, d, f). The data from all donors (donors 1 to 3) were combined and error bars represent standard error of the mean (g, h). A Student’s t-test
was performed to determine statistical significance at each time point (*: P ≤ 0.05).
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Figure 2 Early IFN/ISG response to infection with WNVNY99 and WNVNSW2011 in human MoDCs. MoDCs from three separate donors were
infected with WNVNY99 or WNVNSW2011 at MOI = 1 and total cellular RNA was isolated at 24 hours post-infection. vRNA (a), IFNβ (b), OAS1 (c) and
MxA (d) mRNA levels as determined by qRT-PCR were normalised to a combination of three endogenous controls (TBP, GAPDH and PPIA), and
expressed as fold change from uninfected samples. The results show mean values from three different donors (donors 1 to 3) and error bars
represent standard error of the mean. A Student’s t-test was performed to determine statistical significance (*: P ≤ 0.05).
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lation of RIG-1, MDA5 or TLR3 [13]. While comparison
of WNV strains has been previously performed in DCs
to show that WNV strains with glycosylated envelope
(E) protein have increased infection and replication rates
[14], WNVNY99 and WNVNSW2011 both have glycosyl-
ated E [4], and are therefore expected to be equally effi-
cient in viral entry into MoDCs through attachment to
DC-SIGN or DC-SIGNR receptors [11]. Therefore, add-
itional differences must exist that result in either pro-
ductive infection of DCs or effective viral clearance by
the innate immune response.
To investigate this, we used MoDCs by isolating per-
ipheral blood mononuclear cells (PBMCs) from human
buffy coat from three donors, which were tested to be
negative for arboviral infections, then performed CD14+
magnetic selection to isolate monocytes. The isolated
monocytes were cultured with GM-CSF and IL-4 for
6 days to differentiate into immature MoDCs, which
were then matured upon WNV infection represented byFigure 3 Late IFN/ISG and pro-inflammatory cytokine response to inf
from three separate donors were infected with WNVNY99 or WNVNSW2011 at
infection. IFNβ (a), OAS1 (b), MxA (c), TNFα (d) and IL-6 (e) mRNA levels as d
endogenous controls (TBP, GAPDH and PPIA), and expressed as fold change
different donors (donors 1 to 3) and error bars represent standard error of
significance at each time point (*: P ≤ 0.05).increased CD80 and CD86 expression. Briefly, at 48 hours
post infection (hpi), 78.7% of WNVNY99-infected MoDCs
and 84.5% of WNVNSW2011-infected MoDCs showed
CD80 upregulation, and 93.9% of WNVNY99-infected
MoDCs, 95.8% of WNVNSW2011-infected MoDCs showed
CD86 upregulation.
To compare the ability of WNVNY99 and WNVNSW2011
to productively infect these initial target cells, MoDCs
were infected with WNVNY99 and WNVNSW2011 (passage
1 stocks grown in Vero76 cells) at a multiplicity of infec-
tion (MOI) of 1 and cell culture supernatant and total
cellular RNA was harvested at 24, 48 and 72 hpi. Our re-
sults revealed that WNVNY99 produced similar titers to
WNVNSW2011 at 24 hpi for donor 1 (Figure 1a) and donor
2 (Figure 1c), but less virus compared to WNVNSW2011 for
donor 3 (Figure 1e). At later times of infection (48 and 72
hpi), WNVNY99 consistently produced higher titers than
WNVNSW2011 (Figure 1a, c, and e). A similar trend was
observed by qRT-PCR analysis of intracellular vRNA
levels, showing reduced RNA replication for WNVNY99ection with WNVNY99 and WNVNSW2011 in human MoDCs. MoDCs
MOI = 1 and total cellular RNA was isolated at 48 and 72 hours post-
etermined by qRT-PCR were normalised to a combination of three
from uninfected samples. The results show mean values from three
the mean. A Student’s t-test was performed to determine statistical
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replication for WNVNY99 compared to WNVNSW2011 at
48 and 72 hpi (Figure 1b, d, and f). It was also interesting
to note that for all three donors, WNVNSW2011 viral titers
and vRNA failed to increase after 24 hpi (Figure 1a-f), indi-
cating that WNVNSW2011 could not productively replicate
in MoDCs while WNVNY99 could. In addition, we observed
significant variability between human donors, as cells iso-
lated from donor 3 (Figure 1e and f) were more resistant to
WNV infection than donors 1 and 2 (Figure 1a-d), which
may reflect the high variability in disease symptoms ob-
served in natural human WNV infections [9,15]. When
the data from all three donors were combined, WNVNY99
produced significantly more virus particles at 48 and 72
hpi (p < 0.05, Figure 1g), and replicated to significantly
higher vRNA levels at 72 hpi (p < 0.05, Figure 1h). This
confirms the hypothesis that WNVNY99 was able to repli-
cate more efficiently than WNVNSW2011 in MoDCs, which
could possibly translate into increased dissemination in
the body, and increased virulence. The enhanced replica-
tion of WNVNY99 compared to WNVNSW2011 was similarly
shown in previous studies conducted in our laboratory
using commonly used immortalised cell lines [4,16].
It was hypothesized that differences in replication were
associated with host innate immune response generated
against the viruses. Therefore, qRT-PCR analysis of
IFNβ, OAS1, MxA, TNFα, IL-6 and viral RNA (vRNA)
expression was performed in the context of WNVNY99
and WNVNSW2011 infections. Interestingly, at the early
phase of infection (24 hpi), MoDCs infected with
WNVNY99 had reduced levels of vRNA (p < 0.05, Figure 2a),
IFNβ mRNA (Figure 2b), OAS1 mRNA (Figure 2c) and
MxA mRNA (Figure 2d) compared to MoDCs infected
with WNVNSW2011. In contrast, at the later phase of infec-
tion (48 and 72 hpi), RNA levels for WNVNY99 were in-
creased (Figure 1h), which likely explains the increased
induction of IFNβ (Figure 3a), OAS1 (Figure 3b) and MxA
mRNAs (Figure 3c), as well as a significant increase in in-
duction of proinflammatory cytokines TNFα (48 hpi p <
0.05, Figure 3d) and IL-6 (72 hpi p < 0.05, Figure 3e).
The upregulation of TNFα and IL-6 is likely to occur
via viral dsRNA activation of TLR3 [9,17,18]. Studies
in vivo have shown that TLR3 knockout mice were more
resistant against WNV encephalitis, and this was linked
to decreased TNFα and IL-6 expression [18]. The pro-
posed mechanism of this is that TNFα and IL-6 secreted
into the bloodstream from infected leukocytes may in-
duce endocytosis and degradation of tight junction pro-
teins (Claudin-1, JAM-1 and occludin) of the blood
brain barrier (BBB), causing breakdown of the BBB and
allowing WNV entry into the brain [18-22].
Our finding that WNVNY99, but not WNVNSW2011,
suppresses early viral RNA replication in MoDCs is sup-
ported by previous reports. Scherbik et al. [23] showedthat the pathogenic lineage 1 strain of WNV (Eg101),
but not the non-pathogenic lineage 2 strain (W956IC),
suppressed early viral RNA replication (but increased
viral protein expression), resulting in reduced host in-
nate immune responses at the early phase of infection.
This effect of early IFN suppression was also shown for
pathogenic vs. non-pathogenic Tick Borne Encephalitis
virus (TBEV) strains [24]. These two studies suggest that
pathogenic viral strains more effectively suppress early
viral RNA replication but increase translation, which has
three outcomes that favour virulence; i) decreasing the
amount of viral dsRNA to decrease IFN induction, ii) in-
creased viral non-structural protein production to block
the JAK/STAT signalling cascade, and iii) more effective
viral protein-dependent remodelling of cellular mem-
branes which house replication complexes [23,25].
Taken together, our results have identified that a
possible factor leading to higher human virulence of
WNVNY99 is likely to be decreased viral RNA replication
and lower induction of IFNβ, OAS1 and MxA early in
MoDCs infection. This likely facilitates the enhanced
replication of WNVNY99 vRNA and dissemination of
particles later in infection.
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